You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Delhi govt to procure 6.7 mn Covishield doses from Serum Institute

300,000 shots will be delivered by May 3, official sources said

Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

Photo: Shutterstock
Photo: Shutterstock

The Delhi government will procure 6.7 million doses of Covishield vaccine from Serum Institute of India and the first tranche of 300,000 shots will be delivered by May 3, official sources said on Thursday.

The Delhi government has also sought a supply schedule from the manufacturer for the remaining doses which are to be delivered over the next three months.

An official source said a purchase order has been issued in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII).

Delhi Chief Minister Arvind Kejriwal announced on Thursday that a plan has been formulated to vaccinate all adults against within the next three months.

He said vaccination centres would be set up on a large scale and those eligible must come forward to take the jab.

Earlier in the day, Delhi Health Minister Satyendar Jain said the city "does not have vaccine" doses for inoculating people in the 18-44 age group and purchase orders have been placed with manufacturers for the same.

The minister, however, said preparations to give jabs to people in this category have been completed.

"At present, we don't have vaccine. We have requested the companies to provide it," Jain told reporters when asked if there were enough vaccine available for the 18-44 age group.

"We will tell you in a day or two," he replied to another query about starting the inoculation drive for this category on May 1. The minister also said the manufacturers are yet to provide schedules of vaccine supply to the Delhi government.

Kejriwal had on Monday said everybody aged above 18 would be administered COVID-19 vaccines free of cost in Delhi.

He had said his government had approved the procurement of 1.34 crore vaccine doses from various manufacturers.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, April 29 2021. 20:22 IST